scholarly journals Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 may be predictive of death in Severe Coronavirus Disease 2019 (COVID-19)

Author(s):  
Emily R Bowman ◽  
Cheryl M Ainslie Cameron ◽  
Ann Avery ◽  
Janelle Gabriel ◽  
Aaren Kettelhut ◽  
...  

Abstract People infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) display a wide range of illness, from asymptomatic infection to severe respiratory distress resulting in death. We measured serum biomarkers in uninfected individuals and in individuals with mild, moderate, or critical COVID-19 disease. Levels of monocyte activation (sCD14 and FABP4) and inflammation (TNFR1 and 2) were increased in COVID-19 individuals, regardless of disease severity. Among patients with critical disease, individuals who recovered from COVID-19 had lower levels of TNFR1 and TNFR2 at hospital admission compared to these levels in patients with critical disease that ultimately died.

2019 ◽  
Vol 19 (15) ◽  
pp. 1835-1845
Author(s):  
Ali Hassanzadeh ◽  
Adel Naimi ◽  
Majid F. Hagh ◽  
Raedeh Saraei ◽  
Faroogh Marofi ◽  
...  

Introduction: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL or Apo2L) is a member of the tumor necrosis factor (TNF) superfamily, which stimulates apoptosis in a wide range of cancer cells via binding to death receptors 4 and 5 (DR4/5). Nevertheless, TRAIL has noticeable anti-cancer abilities; some cancer cells acquire resistance to TRAIL, and consequently its potential for inducing apoptosis in target cells is strongly diminished. Acute lymphoblastic leukemia MOLT-4 cell line is one of the most resistant cells to TRAIL that developed resistance to TRAIL via different pathways. We used TRAIL plus kaempferol to eliminate resistance of the MOLT-4 cells to TRAIL. Material and Methods: First, IC50 for kaempferol (95 µM) was determined by using the MTT assay. Second, the viability of the MOLT-4 cells was assayed by FACS after Annexin V/PI staining, following treatment with TRAIL (50 and 100 nM) and kaempferol (95 µM) alone and together. Finally, the expression levels of the candidate genes involved in resistance to TRAIL were assayed by real-time PCR technique. Results: Kaempferol plus TRAIL induced apoptosis robustly in MOLT-4 cells at 12, 24 and 48 hours after treatment. Additionally, we found that kaempferol could inhibit expression of the c-FLIP, X-IAP, cIAP1/2, FGF-8 and VEGF-beta, and conversely augment expression of the DR4/5 in MOLT-4 cells. Conclusion: We suggest that co-treatment of MOLT-4 cells with TRAIL plus kaempferol is a practical and attractive approach to eliminate cancers’ resistance to TRAIL via inhibition of the intracellular anti-apoptotic proteins, upregulation of DR4/5 and also by suppression of the VEGF-beta (VEGFB) and FGF-8 expressions.


1988 ◽  
Vol 263 (21) ◽  
pp. 10262-10266
Author(s):  
N Watanabe ◽  
H Kuriyama ◽  
H Sone ◽  
H Neda ◽  
N Yamauchi ◽  
...  

1997 ◽  
Vol 43 (3) ◽  
pp. 155-157 ◽  
Author(s):  
Toshiyuki Hata ◽  
Takae Kawamura ◽  
Ritsuto Fujiwaki ◽  
Showa Aoki ◽  
Kohkichi Hata ◽  
...  

2004 ◽  
Vol 12 (4) ◽  
pp. 734-739 ◽  
Author(s):  
Paola Di Rocco ◽  
Melania Manco ◽  
Giuseppina Rosa ◽  
Aldo V. Greco ◽  
Geltrude Mingrone

Sign in / Sign up

Export Citation Format

Share Document